Related Experiment Video
Updated: Jun 11, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Tuberous sclerosis complex: linking cancer to metabolism
Virginie Mieulet1, Richard F Lamb
1Department of Oncology, University of Alberta, Edmonton, Alberta, T6G 1Z2, Canada.
Trends in Molecular Medicine
|July 8, 2010
Summary
The TSC1/TSC2 complex controls cell growth via the mTOR pathway. Loss of TSC1/TSC2 can paradoxically restrict tumor growth through compensatory mechanisms, suggesting survival benefits in nutrient-limited environments.
Area of Science:
- Cell Biology
- Oncology
- Metabolic Diseases
Background:
- The TSC1/TSC2 tumor-suppressor complex is a key regulator of cell growth.
- It controls the mammalian target of rapamycin (mTOR) signaling pathway.
- Dysregulation of mTOR contributes to diseases like cancer and diabetes.
Purpose of the Study:
- To investigate the role of TSC1/TSC2 complex function in tumor development.
- To understand the compensatory mechanisms activated upon loss of TSC1/TSC2.
- To explore the implications for tumor evolution in nutrient-limited conditions.
Main Methods:
- Analysis of TSC1/TSC2 complex function.
- Investigation of mTOR signaling pathway activity.
- Study of compensatory mechanisms in tumor cells.
Main Results:
- Abnormal mTOR activation upon TSC1/TSC2 loss can trigger compensatory pathways.
- These compensatory mechanisms restrict malignant tumor development.
- Complete loss of TSC1/TSC2 function is rare in human tumors.
Conclusions:
- Retaining TSC1/TSC2 growth suppressor activity may be advantageous for tumor survival.
- This benefit might be linked to promoting survival in nutrient-limited environments.
- Understanding these complex interactions is crucial for cancer and diabetes research.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...